Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens

By Kosmas C.   Tsavaris N.   Panopoulos C.   Vadiaka M.   Stavroyianni N.   Kourelis T.   Malamos N.   Antonopoulos M.   Kalofonos H.P.  

European Journal of Cancer, Vol. 37, Iss. 8, 2001-05 ,pp. : 972-978

Elsevier

Access to resources Recommend Favorite

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite

Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer

By Mori Kiyoshi   Kamiyama Yukari   Kondo Tetsuro   Kano Yasuhiko   Tominaga Keigo  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 2, 2004-02 ,pp. : 129-132

Springer Publishing Company

Access to resources Recommend Favorite

The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy

By Kaira Kyoichi  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 371-379

Springer Publishing Company

Access to resources Recommend Favorite

Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer

By Antonadou D.   Throuvalas N.   Petridis A.   Bolanos N.   Sagriotis A.   Synodinou M.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 402-408

Elsevier

Access to resources Recommend Favorite